Working… Menu
Trial record 1 of 1 for:    NCT03184558
Previous Study | Return to List | Next Study

Bemcentinib (BGB324) in Combination With Pembrolizumab in Patients With TNBC

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03184558
Recruitment Status : Completed
First Posted : June 12, 2017
Last Update Posted : April 3, 2019
Merck Sharp & Dohme Corp.
Information provided by (Responsible Party):
BerGenBio ASA

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : August 30, 2018
Actual Study Completion Date : August 30, 2018